Stefan Kaufmann, former CEO of Tokyo-based Olympus, stepped down in October after the company investigated an allegation that the executive purchased illegal drugs.

Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.

Officials commissioned the independent review in September in response to a study that found tampons may expose users to metals.

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead ...

Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the ...

Edwards submitted a request for a national coverage determination in February, after receiving FDA approval for its Evoque ...

IPOs in medtech have been sparse, but some analysts said improving market conditions could support a revival of offerings in ...

From challenging market leaders to the growing influence of artificial intelligence, medical device executives had a lot to ...

Inspectors found 111 open tickets for software defects categorized as catastrophic or severe patient harm. Several safety ...

Medtech regulators and watchdogs took a closer look at recalls in 2024. Here’s a recap of notable recalls and product safety actions in the past year.

Just in time for the holiday season, ZuriMED Technologies AG celebrated a significant achievement: FDA clearance of their 510 ...